Market Overview:
The global autoimmune diseases treatment market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The market growth is attributed to the increasing prevalence of autoimmune diseases, rising awareness about available treatments, and technological advancements in the field of autoimmune diseases treatment. The global autoimmune diseases treatment market by type is segmented into blood transfusion, supplements, drugs, physical therapy, and other treatments. The drugs segment accounted for the largest share of the global market in 2017 and is projected to grow at a CAGR of 7.8% from 2018 to 2030. This growth can be attributed to the increasing use of biologics and targeted therapies for treating various types of autoimmune diseases. The global autoimmune diseases treatment market by application is segmented into hospitals, medical centers, and other applications such as research institutes and home care settings.
Product Definition:
Autoimmune Diseases Treatment is the use of drugs or other therapies to treat autoimmune diseases. It is important because it can help relieve symptoms and improve quality of life.
Blood Transfusion:
Blood transfusion is the process of replacing blood that was lost due to injury or disease. It is most commonly used in cases of severe bleeding and anemia. In some cases, it may also be used for treating complications arising from diseases such as cancer, kidney disorders, and liver failure.
According to the American Red Cross (ARC), approximately 40% of patients who have a hemorrhage will die if not treated immediately.
Supplements:
A supplement is any substance, which is added to the regular diet. The substances are used for various purposes such as it enhances performance, helps in weight reduction and increases energy level in the body. In addition, they also help to improve immunity system and protect cells from harmful effects of oxidation.
The global supplements market size was valued at USD 75 billion in 2015.
Application Insights:
The hospital application segment dominated the global market in 2017. This can be attributed to factors such as a high prevalence of patients suffering from autoimmune diseases and increasing awareness among healthcare professionals regarding effective treatment methods. For instance, according to the CDC, around 30 million adults suffer from rheumatoid arthritis or osteoarthritis in the U.S., making it one of the most common chronic diseases there. Similarly, about 2 million people are diagnosed with lupus every year worldwide while around 1 million people are affected by multiple sclerosis (MS) globally.
Medical centers also accounted for a significant share owing to factors such as presence of experienced physicians and staff members skilled in diagnosing.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, favorable reimbursement policies, and increasing prevalence of auto-immune diseases are some factors responsible for its growth. In addition, growing awareness about available treatment options is expected to drive the regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising healthcare expenditure by governments and private sectors in countries such as China and India. Moreover, increasing investments by companies for manufacturing immunosuppressants are also driving this regional market forward with a CAGR of XX% from 2018 to 2030 (USD X million).
In addition, supportive government initiatives pertaining to reimbursement policies have led Asia Pacific into being one of the most lucrative regions within this industry; Japan has been observed offering free drugs on national health insurance since 2014 while other Asian countries offer financial assistance through various programs or subsidies (e.g.
Growth Factors:
- Increasing incidence of autoimmune diseases
- Growing awareness about autoimmune diseases and their treatment options
- Rising demand for better and more effective treatments for autoimmune diseases
- Technological advancements in the field of autoimmune disease treatment
- Growing number of clinical trials for new drugs and therapies for autoimmune diseases
Scope Of The Report
Report Attributes
Report Details
Report Title
Autoimmune Diseases Treatment Market Research Report
By Type
Blood Transfusion, Supplements, Drugs, Physical Therapy, Other
By Application
Hospital, Medical Center, Other
By Companies
Abbott Laboratories, Active Biotech, Eli Lilly, AstraZeneca, Lupin, Amgen, Bristol-Myers Squibb, AutoImmune, Pfizer, GlaxoSmithKline, F. Hoffmann-La Roche, Johnson & Johnson
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
195
Number of Tables & Figures
137
Customization Available
Yes, the report can be customized as per your need.
Global Autoimmune Diseases Treatment Market Report Segments:
The global Autoimmune Diseases Treatment market is segmented on the basis of:
Types
Blood Transfusion, Supplements, Drugs, Physical Therapy, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Medical Center, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Active Biotech
- Eli Lilly
- AstraZeneca
- Lupin
- Amgen
- Bristol-Myers Squibb
- AutoImmune
- Pfizer
- GlaxoSmithKline
- F. Hoffmann-La Roche
- Johnson & Johnson
Highlights of The Autoimmune Diseases Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Blood Transfusion
- Supplements
- Drugs
- Physical Therapy
- Other
- By Application:
- Hospital
- Medical Center
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Autoimmune Diseases Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Autoimmune diseases treatment is a combination of medications and lifestyle changes that help to reduce inflammation and restore balance in the body's immune system. Treatment may also include surgery, radiation therapy, or other treatments.
Some of the major companies in the autoimmune diseases treatment market are Abbott Laboratories, Active Biotech, Eli Lilly, AstraZeneca, Lupin, Amgen, Bristol-Myers Squibb, AutoImmune, Pfizer, GlaxoSmithKline, F. Hoffmann-La Roche, Johnson & Johnson.
The autoimmune diseases treatment market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Autoimmune Diseases Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Autoimmune Diseases Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Autoimmune Diseases Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Autoimmune Diseases Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Autoimmune Diseases Treatment Market Size & Forecast, 2020-2028
4.5.1 Autoimmune Diseases Treatment Market Size and Y-o-Y Growth
4.5.2 Autoimmune Diseases Treatment Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Blood Transfusion
5.2.2 Supplements
5.2.3 Drugs
5.2.4 Physical Therapy
5.2.5 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Medical Center
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Autoimmune Diseases Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Autoimmune Diseases Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Blood Transfusion
9.6.2 Supplements
9.6.3 Drugs
9.6.4 Physical Therapy
9.6.5 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Medical Center
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Blood Transfusion
10.6.2 Supplements
10.6.3 Drugs
10.6.4 Physical Therapy
10.6.5 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Medical Center
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Blood Transfusion
11.6.2 Supplements
11.6.3 Drugs
11.6.4 Physical Therapy
11.6.5 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Medical Center
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Blood Transfusion
12.6.2 Supplements
12.6.3 Drugs
12.6.4 Physical Therapy
12.6.5 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Medical Center
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Blood Transfusion
13.6.2 Supplements
13.6.3 Drugs
13.6.4 Physical Therapy
13.6.5 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Medical Center
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Autoimmune Diseases Treatment Market: Competitive Dashboard
14.2 Global Autoimmune Diseases Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.2 Active Biotech
14.3.3 Eli Lilly
14.3.4 AstraZeneca
14.3.5 Lupin
14.3.6 Amgen
14.3.7 Bristol-Myers Squibb
14.3.8 AutoImmune
14.3.9 Pfizer
14.3.10 GlaxoSmithKline
14.3.11 F. Hoffmann-La Roche
14.3.12 Johnson & Johnson
